NI638333 · Active · incorporated 10 years, 5 months ago · Belfast
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops long-acting ocular drug delivery technologies for ophthalmic diseases.
Re-Vana Therapeutics is a private limited company registered at Companies House under number NI638333, incorporated on 9 May 2016, with a registered office in Belfast. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110), other research and experimental development on natural sciences and engineering (SIC 72190) and other professional, scientific and technical activities n.e.c. (SIC 74909). Sonde has indexed 86 filings for this company, including 4 funding rounds. Its most recent round closed in November 2023, raising £4.7m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 4 | Nov 2023 | £4.7m | £9.63 |
| Round 3 | Nov 2022 | £5.5m | £9.63 |
| Round 2 | May 2020 | £2.5m | £8.19 |
| Round 1 | Nov 2017 | £1.2m | £3.55 |
Showing the 10 most recent of 86 filings.
See the complete cap table with every shareholder, founder tags, dilution across 23 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.